Wadad Saba

1.2k total citations
45 papers, 905 citations indexed

About

Wadad Saba is a scholar working on Cellular and Molecular Neuroscience, Oncology and Neurology. According to data from OpenAlex, Wadad Saba has authored 45 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 14 papers in Oncology and 10 papers in Neurology. Recurrent topics in Wadad Saba's work include Neuroscience and Neuropharmacology Research (18 papers), Drug Transport and Resistance Mechanisms (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Wadad Saba is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Drug Transport and Resistance Mechanisms (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Wadad Saba collaborates with scholars based in France, United States and Sweden. Wadad Saba's co-authors include Michel Bottlaender, Héric Valette, Sébastien Goutal, Frédéric Dollé, Marie‐Anne Peyronneau, Nicolas Tournier, Christine Coulon, Salvatore Cisternino, Frédéric Dollé and Bertrand Kühnast and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Brain.

In The Last Decade

Wadad Saba

44 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wadad Saba France	18	318	248	203	139	117	45	905
Ryuji Nakao Japan	22	371 1.2×	378 1.5×	424 2.1×	157 1.1×	95 0.8×	73	1.3k
Fabien Caillé France	20	182 0.6×	227 0.9×	178 0.9×	253 1.8×	177 1.5×	70	1.1k
Sofie Celen Belgium	23	236 0.7×	528 2.1×	205 1.0×	109 0.8×	129 1.1×	55	1.4k
Sébastien Goutal France	18	181 0.6×	194 0.8×	191 0.9×	317 2.3×	183 1.6×	58	913
Lucette Garreau France	16	519 1.6×	386 1.6×	228 1.1×	71 0.5×	124 1.1×	39	1.1k
Marie‐Anne Peyronneau France	18	159 0.5×	260 1.0×	166 0.8×	236 1.7×	145 1.2×	34	848
Shintaro Nishimura Japan	23	210 0.7×	599 2.4×	321 1.6×	139 1.0×	121 1.0×	76	1.5k
Robert L. Gladding United States	20	347 1.1×	399 1.6×	286 1.4×	330 2.4×	157 1.3×	46	1.3k
Markus Piel Germany	21	302 0.9×	270 1.1×	324 1.6×	68 0.5×	27 0.2×	51	1.2k
Tetsuro Tago Japan	15	180 0.6×	213 0.9×	247 1.2×	81 0.6×	88 0.8×	48	925

Countries citing papers authored by Wadad Saba

Since Specialization

Citations

This map shows the geographic impact of Wadad Saba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wadad Saba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wadad Saba more than expected).

Fields of papers citing papers by Wadad Saba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wadad Saba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wadad Saba. The network helps show where Wadad Saba may publish in the future.

Co-authorship network of co-authors of Wadad Saba

This figure shows the co-authorship network connecting the top 25 collaborators of Wadad Saba. A scholar is included among the top collaborators of Wadad Saba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wadad Saba. Wadad Saba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goutal, Sébastien, Wadad Saba, Fabien Caillé, et al.. (2025). Decreased opioid receptor availability and impaired neurometabolic coupling as signatures of morphine tolerance in male rats: A positron emission tomography study. Biomedicine & Pharmacotherapy. 183. 117848–117848. 1 indexed citations

Leroy, Claire, Wadad Saba, Karine Thibault, et al.. (2023). Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain. Frontiers in Neuroscience. 17. 1181786–1181786. 5 indexed citations

Leroy, Claire & Wadad Saba. (2021). Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders. European Journal of Nuclear Medicine and Molecular Imaging. 49(1). 186–200. 4 indexed citations

Disdier, Clémence, Monique Chalansonnet, F. Gagnaire, et al.. (2017). Brain Inflammation, Blood Brain Barrier dysfunction and Neuronal Synaptophysin Decrease after Inhalation Exposure to Titanium Dioxide Nano-aerosol in Aging Rats. Scientific Reports. 7(1). 12196–12196. 51 indexed citations

Damont, Annelaure, Sébastien Goutal, Sylvain Auvity, et al.. (2016). Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates. European Journal of Pharmaceutical Sciences. 91. 98–104. 10 indexed citations

Auvity, Sylvain, Sébastien Goutal, Benoît Thezé, et al.. (2016). Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal. Drug and Alcohol Dependence. 170. 43–50. 11 indexed citations

Goutal, Sébastien, Sylvain Auvity, Fanny Hauquier, et al.. (2016). Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient. Journal of Pharmaceutical and Biomedical Analysis. 123. 173–178. 20 indexed citations

Peyronneau, Marie‐Anne, Wadad Saba, Sébastien Goutal, et al.. (2013). [18F]Fallypride: Metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method. Nuclear Medicine and Biology. 40(7). 887–895. 4 indexed citations

Peyronneau, Marie‐Anne, Wadad Saba, Sébastien Goutal, et al.. (2012). Metabolism and Quantification of [18F]DPA-714, a New TSPO Positron Emission Tomography Radioligand. Drug Metabolism and Disposition. 41(1). 122–131. 65 indexed citations

10.

Tournier, Nicolas, Salvatore Cisternino, Marie‐Anne Peyronneau, et al.. (2012). Discrepancies in the P-glycoprotein-Mediated Transport of 18F-MPPF: A Pharmacokinetic Study in Mice and Non-human Primates. Pharmaceutical Research. 29(9). 2468–2476. 25 indexed citations

11.

Tournier, Nicolas, Héric Valette, Marie‐Anne Peyronneau, et al.. (2011). Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening. Journal of Nuclear Medicine. 52(3). 415–423. 37 indexed citations

12.

Saba, Wadad, Marie‐Anne Peyronneau, Frédéric Dollé, et al.. (2011). Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling. Nuclear Medicine and Biology. 39(2). 227–233. 14 indexed citations

13.

Saba, Wadad, Héric Valette, Sylvie Granon, et al.. (2010). [¹⁸F]ZW‐104, a new radioligand for imaging α2‐α3‐α4/β2 central nicotinic acetylcholine receptors: Evaluation in mutant mice. Synapse. 64(7). 570–572. 4 indexed citations

14.

Saba, Wadad, Héric Valette, Marie‐Anne Peyronneau, et al.. (2009). [¹¹C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: Preclinical characterisation in nonhuman primate. Synapse. 64(1). 61–69. 47 indexed citations

15.

Valette, Héric, Frédéric Dollé, Wadad Saba, et al.. (2007). [¹⁸F]FPhEP and [¹⁸F]F₂PhEP, two new epibatidine‐based radioligands: Evaluation for imaging nicotinic acetylcholine receptors in baboon brain. Synapse. 61(9). 764–770. 9 indexed citations

16.

Dollé, Frédéric, Françoise Hinnen, Sylvie Mavel, et al.. (2007). One‐step radiosynthesis of [¹⁸F]LBT‐999: a selective radioligand for the visualization of the dopamine transporter with PET. Journal of Labelled Compounds and Radiopharmaceuticals. 50(8). 716–723. 25 indexed citations

17.

Saba, Wadad, Héric Valette, Christine Coulon, et al.. (2006). [¹¹C]LBT‐999: A suitable radioligand for investigation of extra‐striatal dopamine transporter with PET. Synapse. 61(1). 17–23. 17 indexed citations

18.

Chalon, Sylvie, Håkan Hall, Wadad Saba, et al.. (2006). Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter. Journal of Pharmacology and Experimental Therapeutics. 317(1). 147–152. 33 indexed citations

19.

Picard, Fabienne, Denis Servent, Wadad Saba, et al.. (2006). Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 129(8). 2047–2060. 123 indexed citations

20.

Dollé, Frédéric, Patrick Emond, Sylvie Mavel, et al.. (2005). Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. Bioorganic & Medicinal Chemistry. 14(4). 1115–1125. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact